Logistical, technical, and radiation safety aspects of establishing a radiopharmaceutical therapy program: A case in Lutetium‐177 prostate‐specific membrane antigen (PSMA) therapy

Prostate‐specific membrane antigen (PSMA) is a cell surface protein highly expressed in nearly all prostate cancers, with restricted expression in some normal tissues. The differential expression of PSMA from tumor to non‐tumor tissue has resulted in the investigation of numerous targeting strategie...

Descripción completa

Detalles Bibliográficos
Autores principales: Zoberi, Jacqueline E., Garcia‐Ramirez, Jose, Luechtefeld, David, Maughan, Nichole M., Amurao, Maxwell, Oyama, Reiko, Baumann, Brian C., Gay, Hiram A., Michalski, Jeff M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Other Topics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113704/
https://www.ncbi.nlm.nih.gov/pubmed/36637862
http://dx.doi.org/10.1002/acm2.13899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113704/
https://www.ncbi.nlm.nih.gov/pubmed/36637862
http://dx.doi.org/10.1002/acm2.13899

Ejemplares similares